Carson Wealth (CWM LLC)’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.24M | Sell |
5,534
-271
| -5% | -$67.5K | ﹤0.01% | 1421 |
|
|
2025
Q4 | $1.4M | Sell |
5,805
-124
| -2% | -$31.7K | ﹤0.01% | 1320 |
|
|
2025
Q3 | $1.62M | Sell |
5,929
-307
| -5% | -$83.9K | ﹤0.01% | 1181 |
|
|
2025
Q2 | $1.61M | Sell |
6,236
-2,129
| -25% | -$508K | 0.01% | 1028 |
|
|
2025
Q1 | $1.87M | Sell |
8,365
-4,510
| -35% | -$1.05M | 0.01% | 850 |
|
|
2024
Q4 | $2.94M | Buy |
12,875
+4,976
| +63% | +$1.2M | 0.01% | 638 |
|
|
2024
Q3 | $1.93M | Buy |
7,899
+2,192
| +38% | +$490K | 0.01% | 718 |
|
|
2024
Q2 | $1.09M | Buy |
5,707
+524
| +10% | +$106K | 0.01% | 847 |
|
|
2024
Q1 | $1.03M | Buy |
5,183
+735
| +17% | +$135K | 0.01% | 843 |
|
|
2023
Q4 | $765K | Buy |
4,448
+567
| +15% | +$87.1K | ﹤0.01% | 913 |
|
|
2023
Q3 | $574K | Buy |
3,881
+1,200
| +45% | +$217K | ﹤0.01% | 940 |
|
|
2023
Q2 | $586K | Buy |
2,681
+165
| +7% | +$36.8K | ﹤0.01% | 888 |
|
|
2023
Q1 | $551K | Sell |
2,516
-127
| -5% | -$27.6K | ﹤0.01% | 865 |
|
|
2022
Q4 | $550K | Buy |
2,643
+153
| +6% | +$33.6K | ﹤0.01% | 775 |
|
|
2022
Q3 | $543K | Buy |
2,490
+162
| +7% | +$36.9K | ﹤0.01% | 725 |
|
|
2022
Q2 | $488K | Buy |
2,328
+124
| +6% | +$26.4K | ﹤0.01% | 742 |
|
|
2022
Q1 | $535K | Buy |
2,204
+489
| +29% | +$118K | ﹤0.01% | 715 |
|
|
2021
Q4 | $447K | Buy |
+1,715
| New | +$445K | ﹤0.01% | 761 |
|
|
2021
Q2 | $33K | Hold |
134
| – | – | ﹤0.01% | 1574 |
|
|
2021
Q1 | $33K | Hold |
134
| – | – | ﹤0.01% | 1574 |
|
|
2020
Q4 | $33K | Hold |
134
| – | – | ﹤0.01% | 1574 |
|
|
2020
Q3 | $33K | Hold |
134
| – | – | ﹤0.01% | 1574 |
|
|
2020
Q2 | $33K | Hold |
134
| – | – | ﹤0.01% | 1574 |
|
|
2020
Q1 | $33K | Hold |
134
| – | – | ﹤0.01% | 1574 |
|
|
2019
Q4 | $33K | Hold |
134
| – | – | ﹤0.01% | 1574 |
|
|
2019
Q3 | $33K | Hold |
134
| – | – | ﹤0.01% | 1574 |
|
|
2019
Q2 | $33K | Hold |
134
| – | – | ﹤0.01% | 1574 |
|
|
2019
Q1 | $33K | Sell |
134
-1,045
| -89% | -$108K | ﹤0.01% | 1574 |
|
|
2018
Q4 | $134K | Buy |
1,179
+2
| +0.2% | +$214 | ﹤0.01% | 674 |
|
|
2018
Q3 | $136K | Buy |
1,177
+359
| +44% | +$39.3K | ﹤0.01% | 576 |
|
|
2018
Q2 | $85K | Buy |
818
+18
| +2% | +$1.82K | ﹤0.01% | 544 |
|
|
2018
Q1 | $79K | Hold |
800
| – | – | ﹤0.01% | 481 |
|
|
2017
Q4 | $68K | Hold |
800
| – | – | ﹤0.01% | 477 |
|
|
2017
Q3 | $62K | Hold |
800
| – | – | ﹤0.01% | 480 |
|
|
2017
Q2 | $62K | Hold |
800
| – | – | ﹤0.01% | 445 |
|
|
2017
Q1 | $58K | Hold |
800
| – | – | ﹤0.01% | 431 |
|
|
2016
Q4 | $50K | Hold |
800
| – | – | ﹤0.01% | 448 |
|
|
2016
Q3 | $52K | Buy |
+800
| New | +$53.3K | ﹤0.01% | 415 |
|
Other funds holding RMD
VCM
VPM
DAM
Carson Wealth (CWM LLC)'s RMD Position: Q1 2026 in Review
Carson Wealth (CWM LLC) reduced its ResMed (RMD) stake by 4.7% in Q1 2026, selling an estimated $67.5K and leaving 5,534 shares worth $1.24M. The position accounts for ﹤0.01% of the portfolio, ranked #1421.
Carson Wealth (CWM LLC) first reported a position in RMD in Q3 2016 and has held it in 38 quarters since. The position peaked at $2.94M in Q4 2024. 941 funds tracked by Wall St. Rank hold RMD as of Q1 2026.
- Carson Wealth (CWM LLC) held 5,534 shares of ResMed worth $1.24M as of Q1 2026.
- Carson Wealth (CWM LLC) sold 271 ResMed shares in Q1 2026, an estimated $67.5K.
- ResMed made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #1421 holding.
- Carson Wealth (CWM LLC) first reported a position in ResMed in Q3 2016 and has held it in 38 quarters since.
- Carson Wealth (CWM LLC)'s ResMed position peaked at $2.94M in Q4 2024.
- 941 funds tracked by Wall St. Rank held ResMed as of Q1 2026.
Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.